On Friday, Shares of Sprint Corporation (NYSE:S), surged 7.73% to $4.18, after Softbank, a Japanese telecommunications and Internet-services company, said it took an additional $87 million stake in the company, according to AP.
Softbank bought a 78 percent majority stake in Sprint in 2013 for $21.6 billion. It has been cutting jobs and trying to shore up profit at the wireless carrier since then.
Softbank brought 22.8 million additional shares between Monday and Wednesday for $87 million. AP Reports
Sprint Corporation, through its auxiliaries, provides various wireless and wireline communications products and services to consumers, businesses, government subscribers, and resellers in the United States, Puerto Rico, and the U.S. Virgin Islands.
Shares of Lowe’s Companies Inc. (NYSE:LOW), inclined 1.26% to $72.11, during its last trading session.
Lowe’s Companies declared its latest tool to assist Pro customers save time, money and run their businesses more efficiently: a newly improved LowesForPros.com. Through the upgraded site, Pro customers can make and track purchases of more than 500,000 items to run their business from the convenience of a computer, tablet or smartphone and can choose to buy online and pick-up in-store or have orders delivered directly to their business or jobsite.
Lowe’s listened to the Pro customer and designed the new LowesForPros.com to be a complete online solution, offering more efficient functionality that allows Pros to develop requisition lists, access purchase history reports and create custom catalogs. These catalogs enable customers, such as property administration companies, to maintain their brand and design standards across multiple buyers and locations while saving time creating new orders. The website also allows Pro customers to manage their company spend by setting purchase approvals and providing the ability to process tax-exempt transactions.
Lowe’s Companies, Inc. operates as a home improvement retailer. The company offers products for maintenance, repair, remodeling, and home decorating.
Finally, MannKind Corp. (NASDAQ:MNKD), ended its last trade with -1.21% loss, and closed at $4.09.
MannKind declared the appointment of Dr. Raymond Urbanski as its Chief Medical Officer. As Chief Medical Officer, Dr. Urbanski will lead MannKind’s overall drug development activities and will be a member of the Executive Leadership Team.
Dr. Urbanski has more than 25 years of research, clinical and pharmaceutical industry experience developing numerous new drugs and indications across oncology, rheumatology, cardiology, endocrinology, and immunology. He has held CMO roles at Mylan and Metabolix. Formerly he was Vice President at Pfizer, and Vice President and CMO at Suntory Pharmaceuticals. He earned both his MD and Ph.D., Pharmacology and Toxicology from the University of Medicine and Dentistry of New Jersey - New Jersey Medical School.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
